Log In
BCIQ
Print this Print this
 

Verisante Aura (formerly SkinSpect)

  Manage Alerts
Collapse Summary General Information
Company Verisante Technology Inc.
DescriptionNon-invasive optical system
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Other device
Latest Stage of DevelopmentMarketed
Standard IndicationSkin cancer
Indication DetailsAid in assessing skin lesions that may be clinically suspicious for melanoma, squamous cell carcinoma and/or basal cell carcinoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/19/2010

Undisclosed

Undisclosed

0

Get a free BioCentury trial today